04 August 2023
04 August 2023
Areteia reports that dexpramipexole significantly reduced AEC in all doses and was well tolerated in eosinophilic asthma patients.
AAHI is developing a novel RNA vaccine that overcomes manufacturing and storage limitations to increase accessibility.
This new grant extends Addex’s collaboration agreement with Indivior until June 2024 for research into GABAB positive PAM drug candidates.
Progression free survival rate at six months after the first administration of the study medication is the primary endpoint.
As the US Solicitor General takes aim at the Sacklers, another infamous pharma head is back with a new project.
The balloon-catheter technology offloads a drug into the vessel wall that promotes protein linkage for vascular remodelling.
A dose escalation phase, followed by an expansion cohort, is also included in the study.
The gene therapy introduces a normal FKRP gene into the muscle and restores the protein function.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
